|
|
|
| Effects of high-throughput Low-calcium Dialysis on Blood Phosphorus, Calcium and iPTH Levels in Patients with Uremia |
| MENG Xiao-li, MA Huai-ying |
| Department of Nephrology, the second hospital of Chaoyang City, Liaoning Province 122000 |
|
|
|
|
Abstract 【Objective】To observe the effect of high-throughput low-calcium dialysis on uremia treatment and on blood phosphorus, blood calcium and iPTH.【Methods】The patients with uremia who were treated in our hospital from August 2016 to August 2017 were selected as the research subjects. According to the dialysis methods, the patients were divided into high-throughput dialysis group and high-throughput low-calcium dialysis group. The levels of patients' nutrition evaluation score (SGA), blood phosphorus, blood calcium and iPTH were observed before and after dialysis. The blood biochemical indexes and the levels of inflammatory cytokines in the two groups were compared before and after the treatment.【Results】There were no differences in the score of SGA and levels blood phosphorus, blood calcium and iPTH between the two groups before treatment. After treatment, the SGA score of the patients in the observation group was higher than that of the control group, while the levels of blood phosphorus, blood calcium and iPTH were lower than those of the control group. The levels of BUN, SCr and GFR were not significant differences between the two groups before treatment. After treatment, the levels of BUN and SCr in the observation group were lower than those of the control group, while the level of GFR was higher than that of the control group. There was no difference in cytokine levels between the two groups before treatment. After treatment, the levels of IL-18, IL-6 and hs-CRP in the observation group were lower than those in the control group.【Conclusion】High-throughput low-calcium dialysis has a better therapeutic effect on uremia. It can obviously lower the levels of calcium, phosphorus, iPTH and improve renal function.
|
|
Received: 03 August 2018
|
|
|
|
|
|
[1] 孙小伟,李倩.高通量血液透析联合罗盖全对尿毒症患者钙磷代谢紊乱及微炎症状态的影响[J].海南医学,2016,27(20):3331-3334.
[2] 张万超.肾衰宁联合药用炭片治疗血液透析患者高磷血症的疗效观察[J].临床肾脏病杂志,2016,16(2):106-109.
[3] 马丽洁,李忠心,刘婧,等.低钙透析对低甲状旁腺激素血液透析患者矿物质及骨代谢的影响[J].首都医科大学学报,2016,37(2):228-232.
[4] 石丽丽,王夏莲.高通量滤器干预对维持性血液透析患者钙、磷、甲状旁腺的代谢调节作用[J].内科急危重症杂志,2017,23(3):250-251.
[5] 武孟宇,姜涛,高军.醋酸钙与碳酸钙对维持性血液透析患者高磷血症的疗效及安全性对比分析[J].中国医师进修杂志,2016,39(1):60-62.
[6] Qiu PX,Xi SX,Ling Z,et al.Impact of different levels of iPTH on all-cause mortality in dialysis patients with secondary hyperparathyroidism after parathyroidectomy[J].Biomed Res Int,2017,2017(4):6934706.
[7] 徐梦露,徐旭东,李双,等.血液透析联合结肠透析治疗尿毒症患者高磷血症的临床研究[J].中国中西医结合肾病杂志,2016,17(4):321-324.
[8] 罗丹,林彬,张浩,等.高通量血液透析对尿毒症患者血清磷及iPTH清除的疗效观察[J].重庆医学,2016,45(22):3137-3139.
[9] 肖健,马兵,石平.高通量透析对维持性血液透析患者钙磷代谢的影响[J].临床肾脏病杂志,2016,16(8):487-491.
[10] 温玉.高通量血液透析联合低钙透析液与普通透析对尿毒症病人皮肤瘙痒评分及血生化指标的影响对比[J].安徽医药,2017,21(3):496-500. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(2): 301-302. |
|
|
|
|
2020, Vol. 37 
